{ "x402Version": 2, "id": 39419, "slug": "39419", "resource": "https://api.magentlab.com/api/calc/gipss", "description": "Tefferi 2018 GIPSS for primary myelofibrosis: karyotype (favorable 0, unfavorable 1, VHR 2; caller assigns the three-tier class), absence of type 1/like CALR 1, ASXL1 1, SRSF2 1, U2AF1Q157 1 (not S34); max 6. Low 0, intermediate_1 1, intermediate_2 2, high ≥3. Published median (5-year) survivals 26.4 y (94%), 8.0 y (73%), 4.2 y (40%), 2 y (14%). Not DIPSS or MIPSS70-plus. magent does not karyotype or sequence.", "type": "http", "serviceName": "magent", "resourceType": "Agent Service", "accepts": [ { "scheme": "exact", "network": "eip155:8453", "payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2", "asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913", "amount": "5000", "amountUsd": 0.005, "maxTimeoutSeconds": 600 } ], "outputSchema": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" }, "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "asxl1_mutated": false, "calr_type1_like": true, "karyotype": "favorable", "srsf2_mutated": false, "u2af1_q157_mutated": false }, { "asxl1_mutated": false, "calr_type1_like": true, "karyotype": "favorable", "srsf2_mutated": false, "u2af1_q157_mutated": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "asxl1_mutated": false, "calr_type1_like": true, "citation": { "authors": "Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Begna KH, Gangat N, Pardanani A, Vannucchi AM", "doi": "10.1038/s41375-018-0107-z", "id": "tefferi-2018", "pmid": "29654267", "source": "Leukemia. 2018;32(7):1631-1642", "title": "GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis" }, "components": [ { "factor": "karyotype", "points": 0, "present": false, "value": "favorable" }, { "factor": "absence_of_calr_type1_like", "points": 0, "present": false }, { "factor": "asxl1_mutated", "points": 0, "present": false }, { "factor": "srsf2_mutated", "points": 0, "present": false }, { "factor": "u2af1_q157_mutated", "points": 0, "present": false } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "five_year_survival_percent": 94, "formula": "gipss", "formula_expression": "GIPSS = karyotype (favorable 0, unfavorable 1, vhr 2) + absence of type 1/like CALR 1 + asxl1_mutated 1 + srsf2_mutated 1 + u2af1_q157_mutated 1; Tefferi 2018; max 6; low 0, intermediate_1 1, intermediate_2 2, high ≥3", "karyotype": "favorable", "max_score": 6, "median_survival_years": 26.4, "risk_group": "low", "score": 0, "srsf2_mutated": false, "u2af1_q157_mutated": false }, { "asxl1_mutated": false, "calr_type1_like": true, "citation": { "authors": "Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Begna KH, Gangat N, Pardanani A, Vannucchi AM", "doi": "10.1038/s41375-018-0107-z", "id": "tefferi-2018", "pmid": "29654267", "source": "Leukemia. 2018;32(7):1631-1642", "title": "GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis" }, "components": [ { "factor": "karyotype", "points": 0, "present": false, "value": "favorable" }, { "factor": "absence_of_calr_type1_like", "points": 0, "present": false }, { "factor": "asxl1_mutated", "points": 0, "present": false }, { "factor": "srsf2_mutated", "points": 0, "present": false }, { "factor": "u2af1_q157_mutated", "points": 0, "present": false } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "five_year_survival_percent": 94, "formula": "gipss", "formula_expression": "GIPSS = karyotype (favorable 0, unfavorable 1, vhr 2) + absence of type 1/like CALR 1 + asxl1_mutated 1 + srsf2_mutated 1 + u2af1_q157_mutated 1; Tefferi 2018; max 6; low 0, intermediate_1 1, intermediate_2 2, high ≥3", "karyotype": "favorable", "max_score": 6, "median_survival_years": 26.4, "risk_group": "low", "score": 0, "srsf2_mutated": false, "u2af1_q157_mutated": false } ], "path": "/api/calc/gipss" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "asxl1_mutated": { "description": "ASXL1 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence.", "type": "boolean" }, "calr_type1_like": { "description": "Presence of a type 1/like CALR mutation as assigned by the caller (Tefferi 2018). false (absence) scores 1. true scores 0. Type 2/like CALR, JAK2, MPL, and triple-negative are absence of type 1/like CALR. magent does not sequence.", "type": "boolean" }, "karyotype": { "description": "Tefferi 2018 revised three-tier karyotype as assigned by the caller (mutually exclusive). favorable is a normal karyotype or sole 13q−, +9, 20q−, chromosome 1 translocation/duplication, or sex chromosome abnormality including −Y and scores 0. unfavorable is all other abnormalities and scores 1. vhr is very high risk: single/multiple −7, i(17q), inv(3)/3q21, 12p−/12p11.2, 11q−/11q23, +21, or other autosomal trisomies not including +8/+9 and scores 2. magent does not karyotype.", "enum": [ "favorable", "unfavorable", "vhr" ], "type": "string" }, "srsf2_mutated": { "description": "SRSF2 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence.", "type": "boolean" }, "u2af1_q157_mutated": { "description": "U2AF1 Q157 mutation (Q157P or Q157R) as assigned by the caller (Tefferi 2018). true scores 1. U2AF1 S34 does not score. magent does not sequence.", "type": "boolean" } }, "required": [ "karyotype", "calr_type1_like", "asxl1_mutated", "srsf2_mutated", "u2af1_q157_mutated" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } }, "tags": [ "gipss", "myelofibrosis", "hematology", "prognosis", "karyotype", "bazaar" ], "sourceHost": "api.magentlab.com", "lastUpdated": "2026-10-12T14:55:34.394Z", "quality": { "calls30d": 4, "uniquePayers30d": 2, "lastCalledAt": "2026-10-12T14:55:34.278Z" }, "metadata": { "serviceName": "magent", "extensions": { "bazaar": { "info": { "iconUrl": "https://api.magentlab.com/favicon.ico", "input": { "body": { "items": [ { "asxl1_mutated": false, "calr_type1_like": true, "karyotype": "favorable", "srsf2_mutated": false, "u2af1_q157_mutated": false }, { "asxl1_mutated": false, "calr_type1_like": true, "karyotype": "favorable", "srsf2_mutated": false, "u2af1_q157_mutated": false } ] }, "method": "POST", "type": "http" }, "output": { "example": { "count": 2, "items": [ { "asxl1_mutated": false, "calr_type1_like": true, "citation": { "authors": "Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Begna KH, Gangat N, Pardanani A, Vannucchi AM", "doi": "10.1038/s41375-018-0107-z", "id": "tefferi-2018", "pmid": "29654267", "source": "Leukemia. 2018;32(7):1631-1642", "title": "GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis" }, "components": [ { "factor": "karyotype", "points": 0, "present": false, "value": "favorable" }, { "factor": "absence_of_calr_type1_like", "points": 0, "present": false }, { "factor": "asxl1_mutated", "points": 0, "present": false }, { "factor": "srsf2_mutated", "points": 0, "present": false }, { "factor": "u2af1_q157_mutated", "points": 0, "present": false } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "five_year_survival_percent": 94, "formula": "gipss", "formula_expression": "GIPSS = karyotype (favorable 0, unfavorable 1, vhr 2) + absence of type 1/like CALR 1 + asxl1_mutated 1 + srsf2_mutated 1 + u2af1_q157_mutated 1; Tefferi 2018; max 6; low 0, intermediate_1 1, intermediate_2 2, high ≥3", "karyotype": "favorable", "max_score": 6, "median_survival_years": 26.4, "risk_group": "low", "score": 0, "srsf2_mutated": false, "u2af1_q157_mutated": false }, { "asxl1_mutated": false, "calr_type1_like": true, "citation": { "authors": "Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Begna KH, Gangat N, Pardanani A, Vannucchi AM", "doi": "10.1038/s41375-018-0107-z", "id": "tefferi-2018", "pmid": "29654267", "source": "Leukemia. 2018;32(7):1631-1642", "title": "GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis" }, "components": [ { "factor": "karyotype", "points": 0, "present": false, "value": "favorable" }, { "factor": "absence_of_calr_type1_like", "points": 0, "present": false }, { "factor": "asxl1_mutated", "points": 0, "present": false }, { "factor": "srsf2_mutated", "points": 0, "present": false }, { "factor": "u2af1_q157_mutated", "points": 0, "present": false } ], "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.", "five_year_survival_percent": 94, "formula": "gipss", "formula_expression": "GIPSS = karyotype (favorable 0, unfavorable 1, vhr 2) + absence of type 1/like CALR 1 + asxl1_mutated 1 + srsf2_mutated 1 + u2af1_q157_mutated 1; Tefferi 2018; max 6; low 0, intermediate_1 1, intermediate_2 2, high ≥3", "karyotype": "favorable", "max_score": 6, "median_survival_years": 26.4, "risk_group": "low", "score": 0, "srsf2_mutated": false, "u2af1_q157_mutated": false } ], "path": "/api/calc/gipss" }, "type": "json" } }, "schema": { "$schema": "https://json-schema.org/draft/2020-12/schema", "properties": { "input": { "additionalProperties": false, "properties": { "body": { "additionalProperties": false, "properties": { "items": { "items": { "properties": { "asxl1_mutated": { "description": "ASXL1 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence.", "type": "boolean" }, "calr_type1_like": { "description": "Presence of a type 1/like CALR mutation as assigned by the caller (Tefferi 2018). false (absence) scores 1. true scores 0. Type 2/like CALR, JAK2, MPL, and triple-negative are absence of type 1/like CALR. magent does not sequence.", "type": "boolean" }, "karyotype": { "description": "Tefferi 2018 revised three-tier karyotype as assigned by the caller (mutually exclusive). favorable is a normal karyotype or sole 13q−, +9, 20q−, chromosome 1 translocation/duplication, or sex chromosome abnormality including −Y and scores 0. unfavorable is all other abnormalities and scores 1. vhr is very high risk: single/multiple −7, i(17q), inv(3)/3q21, 12p−/12p11.2, 11q−/11q23, +21, or other autosomal trisomies not including +8/+9 and scores 2. magent does not karyotype.", "enum": [ "favorable", "unfavorable", "vhr" ], "type": "string" }, "srsf2_mutated": { "description": "SRSF2 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence.", "type": "boolean" }, "u2af1_q157_mutated": { "description": "U2AF1 Q157 mutation (Q157P or Q157R) as assigned by the caller (Tefferi 2018). true scores 1. U2AF1 S34 does not score. magent does not sequence.", "type": "boolean" } }, "required": [ "karyotype", "calr_type1_like", "asxl1_mutated", "srsf2_mutated", "u2af1_q157_mutated" ], "type": "object" }, "maxItems": 25, "minItems": 1, "type": "array" } }, "required": [ "items" ], "type": "object" }, "headers": { "additionalProperties": { "type": "string" }, "type": "object" }, "method": { "const": "POST", "type": "string" }, "type": { "const": "http", "type": "string" } }, "required": [ "type", "method" ], "type": "object" }, "output": { "properties": { "example": { "type": "object" }, "type": { "type": "string" } }, "required": [ "type" ], "type": "object" } }, "required": [ "input" ], "type": "object" } } } }, "liveness": { "reliability": null }, "verified": false, "featured": false, "provider": { "host": "api.magentlab.com", "manifest_name": "api.magentlab.com", "source": "cdp-mirror", "source_manifest_url": "https://api.cdp.coinbase.com/platform/v2/x402/discovery/resources", "submitted_at": "2026-10-14T01:15:01.050Z" }, "exampleResponse": { "example": {}, "type": "string" } }